Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Improving awareness could transform outcomes in degenerative cervical myelopathy [AO Spine RECODE-DCM Research Priority Number 1]
Study Design Literature Review (Narrative) Objective To introduce the number one research
priority for Degenerative Cervical Myelopathy (DCM): Raising Awareness. Methods Raising …
priority for Degenerative Cervical Myelopathy (DCM): Raising Awareness. Methods Raising …
A minimum data set—Core outcome set, core data elements, and core measurement set—For degenerative cervical myelopathy research (AO Spine RECODE DCM) …
Background Degenerative cervical myelopathy (DCM) is a progressive chronic spinal cord
injury estimated to affect 1 in 50 adults. Without standardised guidance, clinical research …
injury estimated to affect 1 in 50 adults. Without standardised guidance, clinical research …
Riluzole for degenerative cervical myelopathy: a secondary analysis of the CSM-PROTECT Trial
Importance The modified Japanese Orthopaedic Association (mJOA) scale is the most
common scale used to represent outcomes of degenerative cervical myelopathy (DCM); …
common scale used to represent outcomes of degenerative cervical myelopathy (DCM); …
Machine learning-based cluster analysis identifies four unique phenotypes of patients with degenerative cervical myelopathy with distinct clinical profiles and long …
Background Degenerative cervical myelopathy (DCM), the predominant cause of spinal cord
dysfunction among adults, exhibits diverse interrelated symptoms and significant …
dysfunction among adults, exhibits diverse interrelated symptoms and significant …
Cervical spondylotic myelopathy with severe axial neck pain: is anterior or posterior approach better?
OBJECTIVE The aim of this study was to determine whether multilevel anterior cervical
discectomy and fusion (ACDF) or posterior cervical laminectomy and fusion (PCLF) is …
discectomy and fusion (ACDF) or posterior cervical laminectomy and fusion (PCLF) is …
Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo …
MG Fehlings, JH Badhiwala, H Ahn… - The Lancet …, 2021 - thelancet.com
Background Degenerative cervical myelopathy represents the most common form of non-
traumatic spinal cord injury. This trial investigated whether riluzole enhances outcomes in …
traumatic spinal cord injury. This trial investigated whether riluzole enhances outcomes in …
Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE …
Objectives To evaluate the measurement properties of outcome measures currently used in
the assessment of degenerative cervical myelopathy (DCM) for clinical research. Design …
the assessment of degenerative cervical myelopathy (DCM) for clinical research. Design …
Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial—study protocol
Introduction Degenerative cervical myelopathy (DCM) is a common and disabling condition
of symptomatic cervical spinal cord compression secondary to degenerative changes in …
of symptomatic cervical spinal cord compression secondary to degenerative changes in …
Develo** peri-operative rehabilitation in degenerative cervical myelopathy [AO Spine RECODE-DCM Research Priority Number 6]: an unexplored opportunity?
Study Design Narrative review. Objective Degenerative cervical myelopathy is one of the
most frequent impairments of the spinal cord encountered internationally in adults. Currently …
most frequent impairments of the spinal cord encountered internationally in adults. Currently …
Outcomes of degenerative cervical myelopathy from the perspective of persons living with the condition: findings of a semistructured interview process with partnered …
Study Design: Mixed-methods cross-sectional study. Objectives: Degenerative cervical
myelopathy (DCM) is a common and disabling condition. While classically, assessment and …
myelopathy (DCM) is a common and disabling condition. While classically, assessment and …